Jae-sik Kim, CEO of PH Pharma “Targeting the global market with glaucoma drugs”

Specializes in glaucoma, which is common in Asians

Develops treatment for non-alcoholic steatohepatitis Secured multiple chemical anticancer toxin molecules

(For more information, please refer to the link below)

http://news.hankyung.com/article/read/201811224326f